News
Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board ...
Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have made one of the most ...
In March, the journal Nature published the discoveries of two paradigm-breaking antimicrobial compounds in as many weeks: a ...
In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.
Acetaminophen may be doing more than just dulling pain in your brain it could be stopping it before it even starts. Scientists at Hebrew University have discovered that a metabolite of the drug, AM404 ...
Naples-based Enveric Biosciences secured a new U.S. patent for novel compounds targeting melatonin receptors, advancing drug development for sleep and mental health disorders.
Law enforcement officials said they confiscated multiple dogs, an alligator, young raccoons and turtles that had been abused from a property they were investigating.
The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global ...
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development ...
JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...
18h
Techno-Science.net on MSNDiscovery: a painkiller without side effectsA team of researchers has made a major breakthrough in the field of painkillers. The compound SBI-810 could be a game-changer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results